CClinicalTrials.gg
CompletedNCT00453843Updated Oct 30, 2012

Shoulder, or Elbow, or Wrist: What Should we Train First After a Stroke?

A Phase 2 interventional study of rehabilitation robotics and Movement therapy in Stroke, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2012-10-30.

Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
190
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

We will test on persons with chronic impairment due to stroke:

  1. whether the order in which robot therapy is delivered influences outcomes (shoulder-and-elbow before wrist vs. wrist before shoulder-and-elbow).
  2. whether we should train the shoulder, elbow, and wrist at the same time or on different days.
Read the detailed description

The Effect of Proximal and Distal Training on Stroke Recovery:

Specific Aim 1. Test whether task specific wrist robotic training improves motor performance among persons with chronic impairment after stroke.

Specific Aim 2. Test whether the order in which robot therapy is delivered influences outcomes (shoulder-and-elbow before wrist vs. wrist before shoulder-and-elbow).

Specific Aim 3. Test whether there is generalization across different joints (shoulder \& elbow vs wrist).

Specific Aim 4: Test whether there is any interference between training across different joints among persons with chronic impairment after stroke.

Briefly we will invite persons with chronic impairment due to stroke to participate in a study that will train them first on wrist for 6 weeks and then on the shoulder-and-elbow for an additional 6 weeks or vice-versa. A third group will train in alternate days for 12 weeks on the shoulder-and-elbow or the wrist, while a fourth group will be trained on the shoulder, elbow, and wrist on the same day. Outcomes will be measured using standard instruments as well as robot-based measures. We expect that results from this study will provide an objective basis for maximizing this kind of therapy.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Stroke
  • movement therapy
  • robotics
  • rehabilitation robotics
  • shoulder, elbow, wrist
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 190 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is the lead sponsor of 416 studies on the registry; 25 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 10 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Patients will be included in the study if they meet the following criteria:

  1. naïve subjects who have never experienced robot-assisted therapy as inpatients or outpatients;
  2. first single focal unilateral lesion with diagnosis verified by brain imaging (MRI or CT scans) that has occurred at least 6 months prior;
  3. cognitive function sufficient to understand the experiments and follow instructions (Mini-Mental Status Score of 22 and higher or interview for aphasic subjects);
  4. average Motor Power score >= 1/5 or \<= 3/5 (neither hemiplegic nor fully recovered motor function in 6 muscles of the shoulder, elbow, and wrist);
  5. informed written consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

Patients will be excluded from the study if they have a fixed contraction deformity in the affected limb.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
190 participants (actual)

Study arms

  • Experimental
    proximal to distal training

    Device: rehabilitation robotics · Procedure: Movement therapy

  • Experimental
    distal to proximal

    Device: rehabilitation robotics · Procedure: Movement therapy

  • Experimental
    proximal and distal on alternate days

    Device: rehabilitation robotics · Procedure: Movement therapy

  • Experimental
    proximal and distal same day

    Device: rehabilitation robotics · Procedure: Movement therapy

Interventions

  • Devicerehabilitation robotics

    sequence of intervention

    Also known as: InMotion2.0 (InMotion Arm) and InMotion3.0 (InMotion Wrist)

  • ProcedureMovement therapy

    sequence of intervention

    Also known as: InMotion2.0 (InMotion Arm) and InMotion3.0 (InMotion Wrist)

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer

    Time frame: 3 times at baseline, midpoint, completion intervention, and at follow-up

  2. Motor Power

    Time frame: 3 times at baseline, midpoint, completion intervention, and at follow-up

Secondary outcomes

  1. Wolf Motor Function

    Time frame: 3 times at baseline, midpoint, completion intervention, and at follow-up

  2. SIS

    Time frame: 3 times at baseline, midpoint, completion intervention, and at follow-up

07

Study locations

1 site
  • Burke Medical Research Institute
    White Plains, New York 10605, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00453843
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborators
Burke Medical Research Institute
Responsible party
Sponsor
First posted
Mar 29, 2007
Start date
Jun 2004
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Oct 30, 2012

Study contacts

Hermano I Krebs, PhD
principal investigator · Massachusetts Institute of Technology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion